Quantcast

Latest otitis media Stories

2010-09-08 14:15:51

The likelihood that the treatment of a middle ear infection will fail is slightly higher for a child who is given a shorter course of antibiotics, according to a new Cochrane Systematic Review. The results are conclusive, but the researchers say there are other factors that must be considered when the drugs are prescribed. Most children suffer at some point from a middle ear infection, also called acute otitis media (AOM). It is one of the most common reasons for children being prescribed...

2010-08-23 11:01:00

NEW YORK, Aug. 23 /PRNewswire-FirstCall/ -- The World Health Organization (WHO) has granted prequalification to Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine. WHO prequalification allows for the...

2010-08-10 13:27:34

Research has documented that ethnic and socioeconomic disparities exist among patients with conditions such as heart disease and diabetes. Now, a new study by researchers from UCLA and Harvard University has found disparities among children suffering from repeated ear infections. The findings, published in the August edition of the journal Laryngoscope, show that frequent ear infections plague white children and children living below the poverty level more than children of other racial or...

2010-07-29 02:58:00

LONDON, July 29, 2010 /PRNewswire/ -- CMP Therapeutics (CMPT) is pleased to announce the appointment of Dr Neill Moray Mackenzie to the role of Chief Executive Officer. Dr Mackenzie brings to CMPT a long record of executive board level management within the biotechnology and pharmaceutical industries at companies including Cambridge Genetics Ltd, Oxford Biomedica plc (an LSE listed company), Avidex Ltd (now Immunocore) and most recently as the SVP for Business Development and Corporate...

2010-07-06 14:13:52

Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBioâ“ž¢, the online open-access journal of the American Society for...

2010-06-22 15:17:08

A history of ear tubes to treat infections does not appear to adversely affect children with cochlear implants, regardless of whether the tubes are left in place or removed before implantation, according to a report in the June issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. Newborn hearing screening is now widespread and cochlear implants to reverse hearing loss have been shown to be successful in children younger than age 2, according to...

12ac0502d93129cb6b62a9bc6e004920
2010-05-02 09:00:00

Despite their widespread use by parents and caregivers, over-the-counter (OTC) cold and cough medicines have carried a warning by the FDA since 2008, and still have the potential to cause serious adverse events in infants and children. Conservative therapies, including nasal suctioning, humidification, and nasal saline, should be recommended over routine use of OTC cough/cold products in infants and children, according to a new commentary published in the May 2010 issue of Otolaryngology...

2010-02-24 10:14:00

Successor to Prevnar is intended for infants, young children SILVER SPRING, Md., Feb. 24 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the...

2010-02-17 07:00:00

SAN DIEGO, Feb. 17 /PRNewswire/ -- Otonomy, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing. The FDA clearance enables Otonomy to move forward with the first clinical trial of a sustained release drug delivered by direct otic injection. Using an...

2009-10-07 15:02:38

Strides in improving the nation's air quality over the past ten years may be a factor in fewer cases of ear infections (otitis media) in children. These results are according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA. The study, which used National Health Interview Survey data of 120,060 children from 1997-2006, measured how many instances occurred in the previous year...


Latest otitis media Reference Libraries

Politzerization
2012-12-31 12:28:34

In 1861 Adam Politzer of Vienna spent much time studying the air movement in the Eustachian tubes and the ear canal. He would measure the air movement by attaching a manometer, a very large gauge, to the ear canal and the pharynx. He developed an apparatus known as the Politzer bag in 1863 which is a less invasive way to clear the Eustachian tubes. Procedure Politzerization, also known as the Politzer maneuver, is a medical procedure which inserts air in the middle ear while the patient...

More Articles (1 articles) »
Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'